Pacira BioSciences Inc’s recent filing unveils that its Director PACE GARY W unloaded Company’s shares for reported $2.75 million on Mar 08 ’24. In the deal valued at $30.60 per share,90,000 shares were sold. As a result of this transaction, PACE GARY W now holds 22,127 shares worth roughly $0.63 million.
Then, PACE GARY W sold 28,257 shares, generating $870,598 in total proceeds. Upon selling the shares at $30.81, the Director now owns 112,127 shares.
Before that, PACE GARY W sold 1,066 shares. Pacira BioSciences Inc shares valued at $31,628 were divested by the Director at a price of $29.67 per share. As a result of the transaction, PACE GARY W now holds 140,384 shares, worth roughly $4.0 million.
A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in mid December with a ‘”an Outperform”‘ rating. TD Cowen also remained covering PCRX and has increased its forecast on August 03, 2023 with a “an Outperform” recommendation from previously “Market perform” rating.
Price Performance Review of PCRX
On Tuesday, Pacira BioSciences Inc [NASDAQ:PCRX] saw its stock jump 0.14% to $28.52. Over the last five days, the stock has gained 0.04%. Pacira BioSciences Inc shares have fallen nearly -15.47% since the year began. Nevertheless, the stocks have fallen -31.98% over the past one year. While a 52-week high of $48.60 was reached on 01/08/24, a 52-week low of $25.93 was recorded on 02/08/24. SMA at 50 days reached $29.73, while 200 days put it at $32.14. A total of 0.36 million shares were traded, compared to the trading of 0.4 million shares in the previous session.
Levels Of Support And Resistance For PCRX Stock
The 24-hour chart illustrates a support level at 28.05, which if violated will result in even more drops to 27.59. On the upside, there is a resistance level at 28.91. A further resistance level may holdings at 29.31. The Relative Strength Index (RSI) on the 14-day chart is 43.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.49, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.33%. Stochastics %K at 18.23% indicates the stock is a buying.
How much short interest is there in Pacira BioSciences Inc?
A steep rise in short interest was recorded in Pacira BioSciences Inc stocks on Mar 15, 2024, growing by 0.13 million shares to a total of 4.07 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 3.94 million shares. There was a rise of 3.19%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 12.20% of the overall stock float, the days-to-cover ratio (short ratio) rose to 8.09.
